The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors (original) (raw)

• Cohen, J. The immunopathogenesis of sepsis. Nature 420, 885–891 (2002).
  Article CAS Google Scholar
• Nathan, C. Points of control in inflammation. Nature 420, 846–852 (2002).
  Article CAS Google Scholar
• Akira, S., Takeda, K. & Kaisho, T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675–680 (2001).
  Article CAS Google Scholar
• Liew, F.Y., Xu, D., Brint, E.K. & O'Neill, L.-A. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5, 446–458 (2005).
  Article CAS Google Scholar
• Wang, J., Hu, Y., Deng, W.W. & Sun, B. Negative regulation of Toll-like receptor signaling pathway. Microbes Infect. 11, 321–327 (2009).
  Article Google Scholar
• Seol, W., Choi, H.S. & Moore, D.D. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272, 1336–1339 (1996).
  Article CAS Google Scholar
• Lee, Y.S., Chanda, D., Sim, J., Park, Y.Y. & Choi, H.S. Structure and function of the atypical orphan nuclear receptor small heterodimer partner. Int. Rev. Cytol. 261, 117–158 (2007).
  Article CAS Google Scholar
• Båvner, A., Sanyal, S., Gustafsson, J.A. & Treuter, E. Transcriptional corepression by SHP: molecular mechanisms and physiological consequences. Trends Endocrinol. Metab. 16, 478–488 (2005).
  Article Google Scholar
• Chanda, D., Park, J.H. & Choi, H.S. Molecular basis of endocrine regulation by orphan nuclear receptor Small Heterodimer Partner. Endocr. J. 55, 253–268 (2008).
  Article CAS Google Scholar
• Zhang, Y. et al. Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation. Hepatology 48, 289–298 (2008).
  Article Google Scholar
• Chen, Z.J. Ubiquitin signalling in the NF-κB pathway. Nat. Cell Biol. 7, 758–765 (2005).
  Article CAS Google Scholar
• Imperatore, F. et al. Hyperbaric oxygen therapy prevents vascular derangement during zymosan-induced multiple-organ-failure syndrome. Intensive Care Med. 30, 1175–1181 (2004).
  Article Google Scholar
• Yoshitomi, H. et al. A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J. Exp. Med. 201, 949–960 (2005).
  Article CAS Google Scholar
• Chiu, Y.H., Macmillan, J.B. & Chen, Z.J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138, 576–591 (2009).
  Article CAS Google Scholar
• Gitlin, L. et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. USA 103, 8459–8464 (2006).
  Article CAS Google Scholar
• Dong, C., Davis, R.J. & Flavell, R.A. MAP kinases in the immune response. Annu. Rev. Immunol. 20, 55–72 (2002).
  Article CAS Google Scholar
• Häcker, H. & Karin, M. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006, re13 (2006).
  Article Google Scholar
• Hoffmann, A. & Baltimore, D. Circuitry of nuclear factor κB signaling. Immunol. Rev. 210, 171–186 (2006).
  Article Google Scholar
• Kawai, T. & Akira, S. Signaling to NF-κB by Toll-like receptors. Trends Mol. Med. 13, 460–469 (2007).
  Article CAS Google Scholar
• Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783–801 (2006).
  Article CAS Google Scholar
• Janeway, C.A. Jr. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197–216 (2002).
  Article CAS Google Scholar
• Sun, S.C. Deubiquitylation and regulation of the immune response. Nat. Rev. Immunol. 8, 501–511 (2008).
  Article CAS Google Scholar
• Deng, L. et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351–361 (2000).
  Article CAS Google Scholar
• Fogarty, S. et al. Calmodulin-dependent protein kinase kinase-β activates AMPK without forming a stable complex: synergistic effects of Ca2+ and AMP. Biochem. J. 426, 109–118 (2010).
  Article CAS Google Scholar
• Hardie, D.G. New roles for the LKB1→AMPK pathway. Curr. Opin. Cell Biol. 17, 167–173 (2005).
  Article CAS Google Scholar
• Chanda, D. et al. Hepatocyte growth factor family negatively regulates hepatic gluconeogenesis via induction of orphan nuclear receptor small heterodimer partner in primary hepatocytes. J. Biol. Chem. 284, 28510–28521 (2009).
  Article CAS Google Scholar
• Kim, Y.D. et al. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 57, 306–314 (2008).
  Article CAS Google Scholar
• Liu, Q.P., Fruit, K., Ward, J. & Correll, P.H. Negative regulation of macrophage activation in response to IFN-γ and lipopolysaccharide by the STK/RON receptor tyrosine kinase. J. Immunol. 163, 6606–6613 (1999).
  CAS PubMed Google Scholar
• Goodwin, B. et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 6, 517–526 (2000).
  Article CAS Google Scholar
• Lam, I.P., Lee, L.T., Choi, H.S., Alpini, G. & Chow, B.K. Bile acids inhibit duodenal secretin expression via orphan nuclear receptor small heterodimer partner (SHP). Am. J. Physiol. Gastrointest. Liver Physiol. 297, G90–G97 (2009).
  Article CAS Google Scholar
• Rothlin, C.V., Ghosh, S., Zuniga, E.I., Oldstone, M.B. & Lemke, G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131, 1124–1136 (2007).
  Article CAS Google Scholar
• Zhang, Y. et al. Nuclear receptor SHP, a death receptor that targets mitochondria, induces apoptosis and inhibits tumor growth. Mol. Cell. Biol. 30, 1341–1356 (2010).
  Article CAS Google Scholar
• Wang, Y. et al. Association of β-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 7, 139–147 (2006).
  Article CAS Google Scholar
• Miao, J. et al. Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation. Genes Dev. 23, 986–996 (2009).
  Article CAS Google Scholar
• Viollet, B. et al. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. Diabetes Metab. 33, 395–402 (2007).
  Article CAS Google Scholar
• Sag, D., Carling, D., Stout, R.D. & Suttles, J. Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 181, 8633–8641 (2008).
  Article CAS Google Scholar
• Zhao, X. et al. Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L497–L504 (2008).
  Article CAS Google Scholar
• Jhun, B.S. et al. 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages. Biochem. Biophys. Res. Commun. 318, 372–380 (2004).
  Article CAS Google Scholar
• Han, S., Stuart, L.A. & Degen, S.-J. Characterization of the DNF15S2 locus on human chromosome 3: identification of a gene coding for four kringle domains with homology to hepatocyte growth factor. Biochemistry 30, 9768–9780 (1991).
  Article CAS Google Scholar
• Bezerra, J.A., Witte, D.P., Aronow, B.J. & Degen, S.J. Hepatocyte-specific expression of the mouse hepatocyte growth factor-like protein. Hepatology 18, 394–399 (1993).
  CAS PubMed Google Scholar
• Wang, M.H., Skeel, A. & Leonard, E.J. Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases. J. Clin. Invest. 97, 720–727 (1996).
  Article CAS Google Scholar
• Chen, Y.Q., Fisher, J.H. & Wang, M.H. Activation of the RON receptor tyrosine kinase inhibits inducible nitric oxide synthase (iNOS) expression by murine peritoneal exudate macrophages: phosphatidylinositol-3 kinase is required for RON-mediated inhibition of iNOS expression. J. Immunol. 161, 4950–4959 (1998).
  CAS PubMed Google Scholar
• Ray, M. et al. Inhibition of TLR4-Induced IκB kinase activity by the RON receptor tyrosine kinase and its ligand, macrophage-stimulating protein. J. Immunol. 185, 7309–7316 (2010).
  Article CAS Google Scholar
• Reichardt, H.M. et al. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J. 20, 7168–7173 (2001).
  Article CAS Google Scholar
• De Bosscher, K., Vanden Berghe, W. & Haegeman, G. The interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev. 24, 488–522 (2003).
  Article CAS Google Scholar
• Ogawa, S. et al. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122, 707–721 (2005).
  Article CAS Google Scholar
• Wang, L. et al. Redundant pathways for negative feedback regulation of bile acid production. Dev. Cell 2, 721–731 (2002).
  Article CAS Google Scholar
• Yang, C.S. et al. Roles of peroxiredoxin II in the regulation of proinflammatory responses to LPS and protection against endotoxin-induced lethal shock. J. Exp. Med. 204, 583–594 (2007).
  Article CAS Google Scholar
• Schingnitz, U. et al. Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J. Immunol. 184, 5271–5279 (2010).
  Article CAS Google Scholar